| RS2151675632 |
PKD1
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic kidney disease, Autosomal dominant polycystic kidney disease |
| RS2151675756 |
ANKRD11
|
Health Risk |
Likely pathogenic |
KBG syndrome, KBG syndrome |
| RS2151676035 |
ANKRD11
|
Health Risk |
Likely pathogenic |
KBG syndrome, KBG syndrome |
| RS2151676915 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2151680679 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2151681264 |
IGF1R
|
Health Risk |
Likely pathogenic |
Microcephaly, Growth delay due to insulin-like growth factor I resistance |
| RS2151682538 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2151684070 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2151684548 |
PKD1
|
Health Risk |
Likely pathogenic |
— |
| RS2151686766 |
PKD1
|
Health Risk |
Pathogenic |
— |
| RS2151687226 |
CHD3
|
Health Risk |
Likely pathogenic |
Snijders Blok-Campeau syndrome, Snijders Blok-Campeau syndrome |
| RS2151688569 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2151689678 |
FANCI
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2151690905 |
IGF1R
|
Health Risk |
Pathogenic |
Growth delay due to insulin-like growth factor I resistance, Growth delay due to insulin-like growth factor I resistance |
| RS2151694492 |
IGF1R
|
Health Risk |
Likely pathogenic |
— |
| RS2151695024 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2151695275 |
PKD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease, adult type |
| RS2151695288 |
PKD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Polycystic kidney disease, adult type |
| RS2151695526 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2151695543 |
PKD1
|
Health Risk |
Pathogenic |
— |
| RS2151695909 |
PKD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease, adult type |
| RS2151697557 |
PKD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease, adult type |
| RS2151697614 |
PKD1
|
Health Risk |
Likely pathogenic |
Autosomal dominant polycystic kidney disease, Autosomal dominant polycystic kidney disease |
| RS2151698069 |
PKD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease, adult type |
| RS2151698853 |
TMEM231
|
Health Risk |
Pathogenic |
— |
| RS2151699315 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2151699891 |
PKD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease, adult type |
| RS2151700036 |
TMEM231
|
Health Risk |
Pathogenic |
Meckel syndrome, type 11 |
| RS2151700092 |
PKD1
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic kidney disease, Polycystic kidney disease |
| RS2151701503 |
ANKRD11
|
Health Risk |
Likely pathogenic |
KBG syndrome, KBG syndrome |
| RS2151701696 |
ANKRD11
|
Health Risk |
Pathogenic |
— |
| RS2151701732 |
LMF1
|
Health Risk |
Likely pathogenic |
— |
| RS2151701755 |
ANKRD11
|
Health Risk |
Pathogenic |
KBG syndrome, KBG syndrome |
| RS2151701893 |
ANKRD11
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, KBG syndrome |
| RS2151701931 |
PRMT7
|
Health Risk |
Likely pathogenic |
Short stature-brachydactyly-obesity-global developmental delay syndrome, Short stature-brachydactyly-obesity-global developmental delay syndrome |
| RS2151701964 |
ANKRD11
|
Health Risk |
Pathogenic |
KBG syndrome, KBG syndrome |
| RS2151702333 |
PKD1
|
Health Risk |
Pathogenic |
— |
| RS2151702587 |
TMEM231
|
Health Risk |
Pathogenic |
Joubert syndrome 20, Meckel syndrome |
| RS2151703086 |
ANKRD11
|
Health Risk |
Likely pathogenic |
Abnormality of the nervous system, Abnormality of the nervous system |
| RS2151703115 |
TMEM231
|
Health Risk |
Pathogenic |
Joubert syndrome 20, Meckel syndrome |
| RS2151703162 |
ANKRD11
|
Health Risk |
Likely pathogenic |
KBG syndrome, KBG syndrome |
| RS2151703192 |
TMEM231
|
Health Risk |
Likely pathogenic |
Meckel syndrome, type 11 |
| RS2151703297 |
ANKRD11
|
Health Risk |
Likely pathogenic |
KBG syndrome, KBG syndrome |
| RS2151703550 |
ANKRD11
|
Health Risk |
Pathogenic |
KBG syndrome, KBG syndrome |
| RS2151704173 |
PKD1
|
Health Risk |
Likely pathogenic |
Enlarged kidney, Hyperechogenic kidneys |
| RS2151704327 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2151704874 |
PKD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease, adult type |
| RS2151707040 |
PKD1
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic kidney disease, Autosomal dominant polycystic kidney disease |
| RS2151707926 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease, adult type |
| RS2151708486 |
IGF1R
|
Health Risk |
Pathogenic |
— |
| RS2151708577 |
PKD1
|
Health Risk |
Likely pathogenic |
— |
| RS2151708652 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2151708812 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2151708958 |
PKD1
|
Health Risk |
Likely pathogenic |
— |
| RS2151710316 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2151710347 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2151710478 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2151710519 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2151710687 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group A |
| RS2151710810 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2151710940 |
TCF12
|
Health Risk |
Pathogenic |
HYPOGONADOTROPIC HYPOGONADISM 26 WITH ANOSMIA, HYPOGONADOTROPIC HYPOGONADISM 26 WITH ANOSMIA |
| RS2151711045 |
PARN
|
Health Risk |
Likely pathogenic |
Dyskeratosis congenita, autosomal recessive 6 |
| RS2151711054 |
TMEM231
|
Health Risk |
Pathogenic |
Meckel syndrome, type 11 |
| RS2151712033 |
ZNF276;FANCA
|
Health Risk |
Pathogenic |
— |
| RS2151712879 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group A |
| RS2151714603 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2151714613 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group A |
| RS2151714666 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2151714692 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2151719218 |
IGF1R
|
Health Risk |
Conflicting classifications of pathogenicity |
Growth delay due to insulin-like growth factor I resistance, Growth delay due to insulin-like growth factor I resistance |
| RS2151724043 |
EVC2
|
Health Risk |
Likely pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2151724149 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2151724213 |
FANCI
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2151725680 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2151726623 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2151726658 |
IGF1R
|
Health Risk |
Likely pathogenic |
Growth delay due to insulin-like growth factor I resistance, Growth delay due to insulin-like growth factor I resistance |
| RS2151726823 |
PKD1
|
Health Risk |
Likely pathogenic |
Autosomal dominant polycystic kidney disease, Polycystic kidney disease |
| RS2151726918 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2151727019 |
PKD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Polycystic kidney disease, adult type |
| RS2151728030 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2151728391 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2151728536 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2151728875 |
ANKRD11
|
Health Risk |
Likely pathogenic |
Global developmental delay, Global developmental delay |
| RS2151728882 |
ANKRD11
|
Health Risk |
Pathogenic |
KBG syndrome, KBG syndrome |
| RS2151729118 |
ANKRD11
|
Health Risk |
Likely pathogenic |
Global developmental delay, Global developmental delay |
| RS2151729320 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2151729404 |
ANKRD11
|
Health Risk |
Pathogenic |
Global developmental delay, Global developmental delay |
| RS2151730040 |
ANKRD11
|
Health Risk |
Likely pathogenic |
— |
| RS2151730424 |
ANKRD11
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2151730563 |
ANKRD11
|
Health Risk |
Pathogenic/Likely pathogenic |
KBG syndrome, KBG syndrome |
| RS2151732018 |
NEK8
|
Health Risk |
Pathogenic |
Renal-hepatic-pancreatic dysplasia 2, Renal-hepatic-pancreatic dysplasia 2 |
| RS2151732133 |
ANKRD11
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2151732245 |
ANKRD11
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2151732301 |
PRMT7
|
Health Risk |
Pathogenic |
Short stature-brachydactyly-obesity-global developmental delay syndrome, Short stature-brachydactyly-obesity-global developmental delay syndrome |
| RS2151732872 |
NEK8
|
Health Risk |
Pathogenic |
Nephronophthisis 9, Nephronophthisis 9 |
| RS2151733047 |
ANKRD11
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS2151733504 |
ANKRD11
|
Health Risk |
Pathogenic |
KBG syndrome, KBG syndrome |
| RS2151733753 |
ANKRD11
|
Health Risk |
Pathogenic |
KBG syndrome, KBG syndrome |
| RS2151734908 |
ANKRD11
|
Health Risk |
Pathogenic |
KBG syndrome, KBG syndrome |
| RS2151735043 |
ANKRD11
|
Health Risk |
Pathogenic |
KBG syndrome, KBG syndrome |